Fertilization outcome, embryo development and birth after unstimulated IVM
- 128 Downloads
A common observation in oocyte in vitro maturation (IVM) cycles is poor embryo quality. However, no study was dedicated to assess zygote and early cleavage embryo quality in IVM cycles. The objective of this study is to analyze fertilization outcome, embryo development and the resulting pregnancy and births in unstimulated IVM cycles.
IVM oocytes were collected 36 h post hCG and matured in vitro for 28–30 h. All oocytes were inseminated by ICSI. Resulting zygotes and embryos were assessed on day-1, 2 and 3, when transfers were made.
The overall oocyte maturation and fertilization rates were 63% and 62%, respectively. Abnormal fertilization rate was 1.7%. Ninety five and 14.6% of the 2Pn zygotes reached the 2-cell and 8 –cell stage at day-2 and day-3, respectively. Embryo quality assessment on day-3 at transfer revealed that only 9% of the embryos were of very good quality. Most embryos showed developmental delay. An average of 3.29 embryos were transferred per patient resulting in implantation and clinical gestation rates of 16% and 32%, respectively. Overall 14 healthy babies were born and there is one ongoing pregnancy.
Results show a significant rate of abnormal fertilization and poor embryo quality after IVM, which is reflected in a higher than average number of embryos being transferred. However, pregnancy, implantation and birth rates are reasonably high and allow us to consider IVM a valuable approach for the treatment of infertility in PCO or PCOS patients.
KeywordsIVM Embryo quality Implantation Pregnancy Births
- 7.Frantz N, Bos-Mikich A, Frantz G, Höher M, Ferreira M. Gravidez após a maturação in vitro de oócitos obtidos sem estimulação hormonal em paciente com ovários policísticos. JBRA. 2008;12:45–7.Google Scholar
- 8.Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W. Exposure to human chorionic gonadotrophin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. Fertil Steril. 2008;89:98–103.PubMedCrossRefGoogle Scholar
- 10.Khashavi Z, Karimzadeh MA. Comparison of unstimulated in vitro maturation and stimulated in vitro fertilization in women with polycystic ovarian syndrome. J Res Med Sci. 2004;6:260–3.Google Scholar
- 11.Le Du, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod. 2005;20:420–4.Google Scholar
- 13.Porter R, Han T, Tucker MJ, Graham J, Liebermann J, Sills ES. Estimation of second polar body retention rate after conventional insemination and intracytoplasmic sperm injection: in vitro observations from more than 5000 human oocytes. J Ass Reprod Genet. 2003;20.Google Scholar
- 14.Rotterdam ESHRE\ASRAM—2004 Sponsored PCOS Consenus Workshop Group. Revised 2003 consensus on diagnotic-criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2003;81:19–25.Google Scholar
- 16.Siristadilis CS, Maheshwari A, Bhattacharya S. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction. Cochrane Database Sys Rev. 2009;21:CD006606.Google Scholar
- 20.Veeck L. Atlas of the Human oocyte and early conceptus, vol.2. Baltimore: Williams & Wilkins; 1999.Google Scholar